✦ LIBER ✦

The influence of fetal sex in screening for Down syndrome in the second trimester using AFP and free β-hCG

✍ Scribed by Kevin Spencer

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 59 KB
Volume: 20
Category: Article
ISSN: 0197-3851
DOI: 10.1002/1097-0223(200008)20:8<648::aid-pd869>3.0.co;2-l

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Screening for Down syndrome using urine

Screening for Down syndrome using urine hCG free β-subunit in the second trimester of pregnancy

✍ Laurence A. Cole; Melissa Jacobs; Taichi Isozaki; Glenn E. Palomaki; Ray O. Baha 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB

Human chorionic gonadotropin (hCG) free beta-subunit levels were determined in 709 control and 13 Down syndrome urine samples from the second trimester of pregnancy. Results were normalized to urine creatinine concentration and converted to multiples of the unaffected pregnancy medium (MOM). The con

The influence of smoking on maternal ser

The influence of smoking on maternal serum AFP and free beta hCG levels and the impact on screening for Down syndrome

✍ Kevin Spencer 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

I have studied the impact of maternal smoking on the levels of maternal serum alpha-fetoprotein (AFP) and free beta human chorionic gonadotrophin (hCG) during the second trimester in a large series (30 727) of self-reported smokers and non-smokers whose pregnancy resulted in the birth of a normal fe

Screening for trisomy 21 in twin pregnan

Screening for trisomy 21 in twin pregnancies in the first trimester using free β-hCG and PAPP-A, combined with fetal nuchal translucency thickness

✍ Kevin Spencer 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

In the ®rst trimester of pregnancy the biochemical markers free b-hCG and pregnancy associated plasma protein-A (PAPP-A) are used for the prenatal screening of trisomy 21, either alone or in combination with nuchal translucency (NT) thickness. In this study, I have analysed the distribution of these

The influence of fetal sex in screening

The influence of fetal sex in screening for trisomy 21 by fetal nuchal translucency, maternal serum free β-hCG and PAPP-A at 10–14 weeks of gestation

✍ Kevin Spencer; Charas Y. T. Ong; Adolfo W. J. Liao; Demetres Papademetriou; Kypr 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 1 views

In a study of 2923 normal pregnancies and 203 pregnancies affected by trisomy 21 we have shown a signi®cant difference in the median MoM of the markers: fetal nuchal translucency, maternal serum free b-hCG and PAPP-A in the presence of a female fetus compared with a male fetus. For maternal serum fr

Urinary free beta hCG, beta core fragmen

Urinary free beta hCG, beta core fragment and total oestriol as markers of Down syndrome in the second trimester of pregnancy

✍ Jenn-Jeih Hsu; Kevin Spencer; David A. Aitken; Jenny Crossley; Theresa Choi; Mik 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB 👁 1 views

In a study of 69 random urine samples from cases of Down syndrome and 405 samples from unaffected pregnancies, we have assessed the value of various candidate markers that have been proposed as tools for screening for Down syndrome. We found that the marker urine free beta hCG in Down syndrome had a

First-trimester screening for Down syndr

First-trimester screening for Down syndrome using nuchal translucency measurement with free β-hCG and PAPP-A between 10 and 13 weeks of pregnancy—the combined test

✍ P. De Biasio; M. Siccardi; G. Volpe; L. Famularo; F. Santi; S. Canini 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 1 views

In a population of 1467 women attending the 'G. Gaslini' Institute for antenatal care, we evaluated first-trimester risk screening for Down syndrome using the 'combined test' based on ultrasound measurement of nuchal translucency (NT), maternal serum pregnancy-associated plasma protein A (PAPP-A) an